Glenview Capital Management, LLC Myriad Genetics Inc Transaction History

Glenview Capital Management, LLC

$5.08 Billion
Q2 2024

A detailed history of Glenview Capital Management, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Glenview Capital Management, LLC holds 3,748,432 shares of MYGN stock, worth $99.2 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares

3,748,432

Previous 4,943,595 24.18%

Holding current value

$99.2 Million

Previous $105 Million 13.01%

% of portfolio

1.81%

Previous 1.85%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $21.5 Million - $30.4 Million	-1,195,163 Reduced 24.18%	3,748,432 $91.7 Million
Q1 2024 May 15, 2024	SELL	$17.59 - $23.59 $5.99 Million - $8.03 Million	-340,387 Reduced 6.44%	4,943,595 $105 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $20.9 Million - $32 Million	1,500,000 Added 39.64%	5,283,982 $101 Million
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $625,113 - $907,762	39,094 Added 1.04%	3,783,982 $60.7 Million
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $7.91 Million - $10.7 Million	-450,224 Reduced 10.73%	3,744,888 $86.8 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $16.7 Million - $26.1 Million	1,097,344 Added 35.42%	4,195,112 $97.5 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $23.7 Million - $34.3 Million	1,636,284 Added 111.96%	3,097,768 $44.9 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $4.28 Million - $6.56 Million	-235,307 Reduced 13.87%	1,461,484 $27.9 Million
Q2 2022 Aug 11, 2022	SELL	$16.45 - $25.88 $661,586 - $1.04 Million	-40,218 Reduced 2.32%	1,696,791 $30.8 Million
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $1.3 Million - $1.6 Million	57,262 Added 3.41%	1,737,009 $43.8 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $13.4 Million - $18.1 Million	-555,421 Reduced 24.85%	1,679,747 $46.4 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $7.22 Million - $8.83 Million	-240,912 Reduced 9.73%	2,235,168 $72.2 Million
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $2.37 Million - $3.04 Million	-93,353 Reduced 3.63%	2,476,080 $75.7 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $22.2 Million - $35.2 Million	-1,113,258 Reduced 30.23%	2,569,433 $78.2 Million
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $11.2 Million - $18.3 Million	924,698 Added 33.53%	3,682,691 $72.8 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $10.7 Million - $14 Million	947,266 Added 52.31%	2,757,993 $36 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $2.9 Million - $4.47 Million	271,196 Added 17.62%	1,810,727 $20.5 Million
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $18.6 Million - $56.3 Million	-1,905,264 Reduced 55.31%	1,539,531 $22 Million
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $4.99 Million - $8.37 Million	-238,511 Reduced 6.48%	3,444,795 $93.8 Million
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $81.3 Million - $173 Million	3,683,306 New	3,683,306 $105 Million

Others Institutions Holding MYGN

# of Institutions

232

Shares Held

92.6M

Call Options Held

117K

Put Options Held

113K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.13B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.

Account

Glenview Capital Management, LLC Myriad Genetics Inc Transaction History